RVTY

Revvity, Inc.

Technology · Laboratory Analytical Instruments
$86.81+0.17% today
AI Take · AlgoThesis

Revvity's 40.2 P/E ratio stands nearly double the sector median, reflecting premium valuation despite the stock sitting 11.22% short of float—a meaningful bearish signal that could amplify any negative catalyst. The RSI at 44.8 suggests neither overbought nor oversold conditions, leaving room for directional movement in either direction. At a $9.7B market cap with above-average multiples, the company commands confidence in growth prospects, yet the elevated valuation paired with notable short interest creates asymmetric risk. This setup implies the market has priced in substantial future expansion; any disappointment could trigger both technical and fundamental selling pressure as shorts capitalize on weakness.

Snapshot

Market cap
$9.7B
P/E
40.2
Forward P/E
15.6
EPS (TTM)
$2.08
Dividend yield
0.32%
Net margin
8.4%
ROE
3.2%
RSI (14)
45
Beta
1.57
Short % of float
11.2%
Days to cover
9.5
52w high
No

Recent headlines

Peers in Laboratory Analytical Instruments

Build a thesis around RVTY

Type a thesis in plain English. AlgoThesis researches it with real data, cites sources, and hands back a tradeable basket.

Open in AlgoThesis →